[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"prebiotic-fiber\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:prebiotic-fiber":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100614661","evaluation-of-vedan-rt-90-resistant-cassava-starch-for-glycemic-control-and-prebiotic-fiber-development-in-a-human-trial-100614661",false,"NCT07282496","Evaluation of VEDAN RT-90 Resistant Cassava Starch for Glycemic Control and Prebiotic Fiber Development in a Human Trial","Inclusion Criteria:\n\n* Subjects aged 18-65 years.\n* Healthy subjects (BMI between 18.5-24.9 kg\u002Fm² for women and men).\n* Subjects must be able to maintain a stable diet (based on the Ministry of Health and Welfare's daily dietary guidelines, with a tolerance of ± 10-15%) and physical activity (based on the World Health Organization's recommendations of 150-300 minutes of moderate-intensity exercise per week, or equivalent physical activity, with a tolerance of ± 20%) during the trial period.\n* Subjects must understand the trial procedures and potential risks and benefits described in the consent form and be able to sign the consent form.\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding women.\n* Subjects with endocrine abnormalities, major organ disease, or mental illness (as determined by a physician).\n* Subjects found to be intolerant to the test sample during the trial.\n* Subjects who develop a disease or take medications or health supplements that could affect the results of the trial during the trial period. (e.g., hypoglycemic (lipid)-lowering medications, probiotics, high-dose dietary fiber supplements, fish oil, or supplements high in polyunsaturated fatty acids).\n* Chronic gastrointestinal diseases (e.g., diverticular disease, irritable bowel syndrome, or other intestinal diseases that may cause constipation).\n* Use of antibiotics within the past three months.",true,"ALL","18 Years","65 Years",{"count":20,"type":21},115,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study aims to investigate the effects of RT-90 resistant cassava starch on glycemic control using a human dietary trial and to evaluate its potential as a prebiotic fiber supplement. This study will assess the efficacy of RT-90 resistant cassava starch in improving glycemic control, body composition, and gut microbiome in healthy individuals.",[27,28,29,30],"Resistant Starch","Tapioca Starch","Prebiotic Fiber","Blood Sugar","NOT_YET_RECRUITING","2025-12-01",{"date":34,"type":35},"2025-12-15","ACTUAL",{"date":37,"type":21},"2025-12-20",{"date":39,"type":21},"2026-10-31",{"name":41,"class":42},"Chung Shan Medical University","OTHER"]